Track Alivus Life Sciences Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Alivus Life Sciences Limited ALIVUS.BO · Stock Open Alivus Life Sciences Limited in new tab

1453.40 INR
P/E
27.94
EPS
54.43
Yield
0.34%
P/B
5.14
ROE
20.15
Beta
0.05
Target Price
1676.25 INR
Loading chart...
Key Metrics
Earnings dateJan. 28, 2027
P/E27.94
EPS54.43
Book Value295.78
Price to Book5.14
Debt/Equity1.46
% Insiders75.955%
Growth
Revenue Growth0.16%
Earnings Growth0.51%
Estimates
Forward P/E22.88
Forward EPS66.46
Target Mean Price1676.25
Dividend
Dividend Yield0.34%
Annual dividends5.00 INR
Ex-Div. DateSept. 1, 2026
Payout9.19%
5y avg Yield1.21%

DCF valuation

Model fair value for Alivus Life Sciences Limited (ALIVUS.BO)
Result
Sign in to run the valuation for ALIVUS.BO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 1676.25 INR (low 1330.00, high 2060.00)
Low 1330.00
Mean 1676.25
High 2060.00
Price 1453.40
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Alivus Life Sciences Limited Logo Alivus Life Sciences Limited Analysis (ALIVUS.BO)

India Healthcare Official Website Stock

Is Alivus Life Sciences Limited a good investment? Alivus Life Sciences Limited (ALIVUS.BO) is currently trading at 1453.40 INR. Market analysts have a consensus price target of 1676.25 INR. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 27.94. This valuation is generally in line with the broader market.

Earnings Schedule: Alivus Life Sciences Limited is expected to release its next earnings report on Jan. 28, 2027. The market consensus estimate for Forward EPS is 66.46.

For income investors, Alivus Life Sciences Limited pays a dividend yield of 0.34%. With a payout ratio of 9%, the dividend appears sustainable.

Investor FAQ

Does Alivus Life Sciences Limited pay a dividend?

Yes, it pays an annual dividend of 5.00 INR (0.34% yield).

What asset class is Alivus Life Sciences Limited?

Alivus Life Sciences Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Jan. 28, 2027. The company currently has a trailing EPS of 54.43.

Company Profile

Alivus Life Sciences Limited develops and manufactures active pharmaceutical ingredients in India, the United States, Europe, Japan, Russia, Brazil, South Korea, Taiwan, Canada, China, and Australia. It offers various APIs, such as amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, solifenacin, atovaquone, etoricoxib, dapagliflozin, and sitagliptin for therapeutic areas, including cardiovascular, central nervous system, diabetes, oncology, urology, and pain management, as well as anti-fungal, anti-histaminic, anti-acne, anti-emetics immunomodulators, anti-ulceratives, immunosuppressant, respiratory agent, ophthalmologic agent, anti-spasmodic, and urology. The company also provides contract development and manufacturing comprising process development, analytical development and support, and API and intermediate manufacturing; and research and development, intellectual property, quality and compliance, customer experience, regulatory support. In addition, it exports its products. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited operates as a subsidiary of Nirma Limited.

Exchange Ticker
BSE ALIVUS.BO
Trades
Dividend Yield
0.34%
5y avg 1.21%
Annual Dividends
5.00INR
Next Ex. Div Date
Sept. 1, 2026
Payout Ratio
9.19%
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
▸2027
5.00 INR
Sept. 13, 2027 (estimated) 5.0000
▸2026
5.00 INR
Sept. 11, 2026 5.0000
▸2025
5.00 INR
Sept. 12, 2025 5.0000
▸2023
43.50 INR
Nov. 8, 2023 22.5000
March 29, 2023 21.0000
▸2022
10.50 INR
Oct. 26, 2022 10.5000
▸2021
10.50 INR
Dec. 10, 2021 10.5000
Upcoming Dividends
Name Payment Date Status Amount
Alivus Life Sciences Limited Sep 11, 2026 5.0 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion